research

The emerging picture is a work-in-progress, but many of the pieces do point toward the potential for airborne transmission.

There is a small chance that Pfizer's vaccine trial will yield results by Nov. 3. But it could still take...

The more physical and occupational therapy visits pneumonia patients receive while hospitalized, the lower the risk of readmission or death,...

The administration calls Moncef Slaoui, who leads its vaccine race, a "contractor" to sidestep rules against personally profiting from government...

Shielding the identities of clinicians and statisticians on the board is meant to insulate them from pressure by the company...

If the executive branch were to overrule the FDA's scientific judgment, a vaccine of limited efficacy and, worse, unknown side...

The development and deployment of a vaccine will affect everybody on the planet. Help us identify and tell important stories.

A new journal article highlights three challenges in accounting for coronavirus deaths and offers solutions.

AstraZeneca, which is running the global trial of the vaccine it produced with Oxford University, said the trial volunteer recovered...

Reduction in the number of days seriously ill coronavirus patients are on mechanical ventilation can reduce respiratory complications.

Photobiomodulation therapy has been an FDA-approved treatment for inflammation and pain since 2011.

In addition to Galgiani's research, the National Institutes for Health's National Institute for Allergy and Infectious Diseases is funding two...